Boul, L., Hallam-Jones, R. & Wylie, K. R. Sexual pleasure and motivation. J. Sex. Marital. Ther. 35, 25–39 (2009).

Article  PubMed  Google Scholar 

Anderson, R. M. Positive sexuality and its impact on overall well-being. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56, 208–214 (2013).

Article  CAS  PubMed  Google Scholar 

Rowland, D. L. Neurobiology of sexual response in men and women. CNS Spectr. 11, 6–12 (2006).

Article  PubMed  Google Scholar 

McCabe, M. P. et al. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J. Sex. Med. 13, 144–152 (2016).

Article  PubMed  Google Scholar 

Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J. & McKinlay, J. B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151, 54–61 (1994).

Article  CAS  PubMed  Google Scholar 

Saitz, T. R. & Serefoglu, E. C. The epidemiology of premature ejaculation. Transl. Androl. Urol. 5, 409–415 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Salonia, A. et al. European Association of Urology guidelines on sexual and reproductive health — 2021 update: male sexual dysfunction. Eur. Urol. 80, 333–357 (2021).

Article  PubMed  Google Scholar 

Parnham, A. & Serefoglu, E. C. Retrograde ejaculation, painful ejaculation and hematospermia. Transl. Androl. Urol. 5, 592–601 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Brotto, L. et al. Psychological and interpersonal dimensions of sexual function and dysfunction. J. Sex. Med. 13, 538–571 (2016).

Article  PubMed  Google Scholar 

Waldinger, M. D., van Gils, A. P., Ottervanger, H. P., Vandenbroucke, W. V. & Tavy, D. L. Persistent genital arousal disorder in 18 Dutch women: part I. MRI, EEG, and transvaginal ultrasonography investigations. J. Sex. Med. 6, 474–481 (2009).

Article  PubMed  Google Scholar 

Waldinger, M. D. & Schweitzer, D. H. Persistent genital arousal disorder in 18 Dutch women: part II. A syndrome clustered with restless legs and overactive bladder. J. Sex. Med. 6, 482–497 (2009).

Article  PubMed  Google Scholar 

Waldinger, M. D. Post orgasmic illness syndrome (POIS). Transl. Androl. Urol. 5, 602–606 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Reisman, Y. Sexual consequences of post-SSRI syndrome. Sex. Med. Rev. 5, 429–433 (2017).

Article  PubMed  Google Scholar 

Gul, M., Towe, M., Yafi, F. A. & Serefoglu, E. C. Hard flaccid syndrome: initial report of four cases. Int. J. Impot. Res. 32, 176–179 (2020).

Article  PubMed  Google Scholar 

Ferini-Strambi, L. et al. Sleep-related painful erections: clinical and polysomnographic features. J. Sleep. Res. 5, 195–197 (1996).

Article  CAS  PubMed  Google Scholar 

Freed, L. Persistent sexual arousal syndrome. J. Sex. Med. 2, 743; author reply 745–746 (2005). 

Article  Google Scholar 

Leiblum, S. R. & Goldmeier, D. Persistent genital arousal disorder in women: case reports of association with anti-depressant usage and withdrawal. J. Sex. Marital. Ther. 34, 150–159 (2008).

Article  PubMed  Google Scholar 

Csoka, A. B. & Shipko, S. Persistent sexual side effects after SSRI discontinuation. Psychother. Psychosom. 75, 187–188 (2006).

Article  PubMed  Google Scholar 

Bahrick, A. S. Persistence of sexual dysfunction side effects after discontinuation of antidepressant medications: emerging evidence. Open Psychol. J. 1, 42–50 (2008).

Article  CAS  Google Scholar 

Halkier-Sorensen, L. Sexual dysfunction in a patient treated with etretinate. Acta Derm. Venereol. 68, 90–91 (1988).

CAS  PubMed  Google Scholar 

Krause, W. Diagnosis of erectile dysfunction in etretinate treatment. Acta Derm. Venereol. 68, 458 (1988).

CAS  PubMed  Google Scholar 

Coleman, R. & MacDonald, D. Effects of isotretinoin on male reproductive system. Lancet 344, 198 (1994).

Article  CAS  PubMed  Google Scholar 

Johnson, M. et al. Differences in polysomnographic, nocturnal penile tumescence and penile doppler ultrasound findings in men with stuttering priapism and sleep-related painful erections. Int. J. Impot. Res. 34, 603–609 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Healy, D. et al. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int. J. Risk Saf. Med. 33, 65–76 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Healy, D., Le Noury, J. & Mangin, D. Post-SSRI sexual dysfunction: patient experiences of engagement with healthcare professionals. Int. J. Risk Saf. Med. 30, 167–178 (2019).

Article  PubMed  Google Scholar 

Gul, M., Huynh, L. M., El-Khatib, F. M., Yafi, F. A. & Serefoglu, E. C. A qualitative analysis of Internet forum discussions on hard flaccid syndrome. Int. J. Impot. Res. 32, 503–509 (2020).

Article  PubMed  Google Scholar 

Russo, G. I. et al. Consulting “Dr Google” for sexual dysfunction: a contemporary worldwide trend analysis. Int. J. Impot. Res. 32, 455–461 (2019).

Article  PubMed  Google Scholar 

Gul, M. & Diri, M. A. YouTube as a source of information about premature ejaculation treatment. J. Sex. Med. 16, 1734–1740 (2019).

Article  PubMed  Google Scholar 

Altintas, E. & Gul, M. The dark side of the internet regarding sexual education. Int. J. Impot. Res. 34, 235–236 (2022).

Article  PubMed  Google Scholar 

Dallob, A. L. et al. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J. Clin. Endocrinol. Metab. 79, 703–706 (1994).

CAS  PubMed  Google Scholar 

Stoner, E. The clinical development of a 5 α-reductase inhibitor, finasteride. J. Steroid Biochem. Mol. Biol. 37, 375–378 (1990).

Article  CAS  PubMed  Google Scholar 

Roehrborn, C. G., Boyle, P., Nickel, J. C., Hoefner, K. & Andriole, G. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 60, 434–441 (2002).

Article  PubMed  Google Scholar 

Irwig, M. S. & Kolukula, S. Persistent sexual side effects of finasteride for male pattern hair loss. J. Sex. Med. 8, 1747–1753 (2011).

Article  PubMed  Google Scholar 

Marks, L. S. 5α-reductase: history and clinical importance. Rev. Urol. 6, S11–S21 (2004).

PubMed  PubMed Central  Google Scholar 

Melcangi, R. C. et al. Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology. J. Sex. Med. 10, 2598–2603 (2013).

Article  CAS  PubMed  Google Scholar 

Traish, A. M. Post-finasteride syndrome: a surmountable challenge for clinicians. Fertil. Steril. 113, 21–50 (2020).

Article  CAS  PubMed  Google Scholar 

McClellan, K. J. & Markham, A. Finasteride: a review of its use in male pattern hair loss. Drugs 57, 111–126 (1999).

Article  CAS  PubMed  Google Scholar 

Carlin, J. R. et al. Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans. Drug. Metab. Dispos. 20, 148–155 (1992).

CAS  PubMed  Google Scholar 

Sung, H. H. et al. Persistent erectile dysfunction after discontinuation of 5-alpha reductase inhibitor therapy in rats depending on the duration of treatment. World J. Mens Health 37, 240–248 (2019).

Article  PubMed  Google Scholar 

Yilmaz-Oral, D. et al. Restorative effects of red onion (Allium cepa L.) juice on erectile function after-treatment with 5α-reductase inhibitor in rats. Int. J. Impot. Res. 34, 269–276 (2022).

Article  CAS  PubMed  Google Scholar 

Gormley, G. J. et al. Effects of finasteride (MK-906), a 5 α-reductase inhibitor, on circulating androgens in male volunteers. J. Clin. Endocrinol. Metab. 70, 1136–1141 (1990).

Article  CAS  PubMed  Google Scholar 

Favilla, V. et al. Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS/BPH: a systematic review with meta-analysis. Aging Male 19, 175–181 (2016).